Chemical Compound

Nosiheptide

CAS Registry Number 56377-79-8
Nosiheptide chemical structure
Primary Record

Nosiheptide

In stock
4,271 g
Purity
98.5 %
CAS
56377-79-8

Compound Identifiers & Properties

CAS
56377-79-8
PubChem CID
16130051
SMILES
CC=C1C2=NC(=CS2)C(=O)NC3CC(C(=O)OCC4=C5C(=C(C(=O)SCC(C6=NC(=CS6)C7=NC(=C(C=C7C8=NC(=CS8)C(=O)NC(C(=O)N1)C(C)O)O)C9=NC(=CS9)C(=O)NC(=C)C(=O)N)NC(=O)C1=CSC3=N1)NC5=CC=C4)C)O
Canonical SMILES
C=C(NC(=O)c1csc(-c2nc3c(cc2O)-c2nc(cs2)C(=O)NC(C(C)O)C(=O)NC(=CC)c2nc(cs2)C(=O)NC2CC(O)C(=O)OCc4cccc5[nH]c(c(C)c45)C(=O)SCC(NC(=O)c4csc2n4)c2nc-3cs2)n1)C(N)=O

Names & Synonyms

  • Nosiheptide
  • Multhiomycin
  • Nosiheptidum
  • nosiheptida
  • Multiomycin
  • Nosheptida
  • Nosiheptid
  • Nosiheptine
  • 56377-79-8
  • RefChem:166740
  • Nosheptida [INN-Spanish]
  • Nosiheptidum [INN-Latin]
  • UNII-F7YI574GFD
  • F7YI574GFD
  • Nosiheptide [USAN:BAN:INN]
  • Nosiheptide [USAN:INN:BAN]
  • DTXCID201517393
  • DTXSID601032385
  • MSK7042-100DM
  • BCP19080
  • RP 9671
  • C51H43N13O12S6
  • EINECS 260-138-4
  • BBF-03904
  • MFCD30718117
  • AKOS032960409
  • NSC-307240
  • RP-9671
  • SB67374
  • BRN 0969123
  • AC-35858
  • AN-40137
  • C51-H43-N13-O12-S6
  • A902567
  • Nosiheptide Solution in DMSO/Methanol, 100ug/mL
  • (2E)-N-(3-amino-3-oxoprop-1-en-2-yl)-2-[(21Z)-21-ethylidene-30-hydroxy-18-(1-hydroxyethyl)-40-methyl-9,16,19,26,31,42,46-heptaoxo-32-oxa-3,13,23,43,49-pentathia-7,17,20,27,45,51,52,53,54,55-decazanonacyclo[26.16.6.1^{2,5.1^{12,15.1^{22,25.1^{38,41.1^{47,50.0^{6,11.0^{34,39]pentapentaconta-2(55),4,6,10,12(54),14,22(53),24,34(39),35,37,40,47,50-tetradecaen-8-ylidene]-3H-1,3-thiazole-4-carboxamide
  • 2-({2-[(21E)-21-ethylidene-9,30-dihydroxy-18-(1-hydroxyethyl)-40-methyl-16,19,26,31,42,46-hexaoxo-32-oxa-3,13,23,43,49-pentathia-7,17,20,27,45,51,52,53,54,55-decaazanonacyclo[26.16.6.1(2),?.1(1)(2),(1)?.1(2)(2),(2)?.1(3)?,?(1).1??,??.0?,(1)(1).0(3)?,(3)?]pentapentaconta-2(55),4,6,8,10,12(54),14,22(53),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-1,3-thiazol-4-yl}formamido)prop-2-enamide
  • 2-[(1S,7S,14S,16S)-10-(Z)-ethylidene-35,16-dihydroxy-7-((R)-1-hydroxy-ethyl)-203-methyl-5,8,12,17,21,25-hexaoxo-201H-18-oxa-22-thia-6,9,13,24-tetraaza-20(4,2)-indola-3(2,3)-pyridina-2,4,11,26(2,4)-tetrakis-thiazola-bicyclo[12.9.3]hexacosaphan-36-yl]-thiazole-4-carboxylic acid 1-carbamoyl-vinylamide
  • 260-138-4
  • N-(1-(Aminocarbonyl)ethenyl)-2-(14-ethylidene-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-hexadecahydro-3,23-dihydroxy-11-(1-hydroxyethyl)-31-methyl-9,12,19,24,33,43-hexaoxo-30,32-imino-8,5:18,15:40,37-trinitrilo-21,36-((2,4)-endo-thiazolomethanimino)-5H,15H,37H-pyrido(3,2-w)(2,11,21,27,31,7,14,17)benzoxatetrathiatriazacyclohexatriacontin-2-yl)-4-thiazolecarboxamide
  • N-(3-Amino-3-Oxoprop-1-En-2-Yl)-2-((11S,14Z,21S,23S,29S)-14-Ethylidene-3,23-Dihydroxy-11-((1R)-(1-Hydroxyethyl))-31-Methyl-9,12,19,24,33,43-Hexaoxo-9,10,11,12,13,14,19,20,21,22,23,24,26,33,35,36-Hexadecahydro-21,36-([2,4]-Endo-Thiazolomethanimino)-5,8:15,18:37,40-Tri(Azeno)-30,32-Epiminobenzo[H1]Pyrido[3,2-V][1]Oxa[10,20,26,30]Tetrathia[6,13,16]Triazacyclohexatriacontin-2-Yl)Thiazole-4-Carboxamide
  • N-(3-amino-3-oxoprop-1-en-2-yl)-2-[(21Z)-21-ethylidene-9,30-dihydroxy-18-(1-hydroxyethyl)-40-methyl-16,19,26,31,42,46-hexaoxo-32-oxa-3,13,23,43,49-pentathia-7,17,20,27,45,51,52,53,54,55-decazanonacyclo[26.16.6.12,5.112,15.122,25.138,41.147,50.06,11.034,39]pentapentaconta-2(55),4,6,8,10,12(54),14,22(53),24,34(39),35,37,40,47,50-pentadecaen-8-yl]-1,3-thiazole-4-carboxamide